• What is VH IVUS?
  • VH IVUS Publications
  • IBIS II Study
  • Culprit of the Culprit
  • About Volcano Corporation

PROSPECT (Providing Regional Observations to Study Predictors of Events in the Coronary Tree) was the first prospective, international, multicenter, natural history study using 3-vessel multimodality intracoronary imaging to quantify the clinical event rate due to atherosclerotic progression and to identify those lesions which place patients at risk for unexpected adverse cardiovascular events. This landmark study of 700 Acute Coronary Syndrome (ACS) patients was co-funded by Volcano and utilized Volcano's proprietary VH® IVUS technology to classify lesions by plaque type. Three-year clinical event data was presented by Dr. Gregg Stone of Columbia University Medical Center on September 24, 2009 at the Transcatheter Cardiovascular Therapeutics (TCT) conference in San Francisco, CA.

View Press Release (PDF)

VH IVUS Lesion Assessment

About Heart Disease

Heart disease and stroke, the principal manifestations of atherosclerotic cardiovascular disease, is the #1 killer of men and women in the Western world. Half of all men will develop heart disease. Atherosclerosis is the underlying mechanism for coronary artery disease, ischemic strokes, and peripheral vascular disease. VH IVUS has the potential to revolutionize the management of coronary artery disease by providing more information about atherosclerosis in the form of arterial plaque composition assessment. Information on the basic composition of coronary plaques has previously been unavailable to clinicians - except at autopsy.